Alexandra Boucher
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023.
Journal: Journal of psychopharmacology (Oxford, England)
Published: February 23, 2026
Accidental protonitazene intoxication: clinical management and detection of a novel opioid.
Journal: BMJ case reports
Published: March 19, 2025
DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in France.
Journal: Therapie
Published: July 15, 2024
Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020.
Journal: Therapie
Published: October 19, 2022
Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
Journal: Therapie
Published: June 16, 2020
Ephenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network.
Journal: Fundamental & clinical pharmacology
Published: November 16, 2017
An unusual case of renal failure in a 22-year-old woman
Journal: La Revue de medecine interne
Published: June 13, 2017
The current aspects of the use of ecstasy/MDMA in France
Journal: Therapie
Published: February 26, 2016
Illicit drugs or medicines taken by parachuting.
Journal: Fundamental & clinical pharmacology
Published: September 18, 2015
Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.
Journal: European journal of clinical pharmacology
Published: August 17, 2015
Last Updated: 09/26/2026